Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Clinical Trials (London, England)|August 26, 2016
A Bayesian response-adaptive trial in tuberculosis: The endTB trialMatteo Cellamare, Steffen Ventz, Elisabeth Baudin, et al.Plos One|December 25, 2013
Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcomeMaryline Bonnet, Elisabeth Baudin, Ilesh V Jani, et al.The Journal of Antimicrobial Chemotherapy|September 21, 2014
Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationshipNilesh B Bhatt, Elisabeth Baudin, Bindiya Meggi, et al.The Lancet. Infectious Diseases|February 26, 2013
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trialMaryline Bonnet, Nilesh Bhatt, Elisabeth Baudin, et al.The Lancet. Global Health|April 27, 2025
Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2-3, non-randomised studyEnock Matovu, Westain Nyirenda, Anthony Eriatu, et al.The Lancet. Infectious Diseases|January 11, 2025
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trialMatthew E Coldiron, Issaka Soumana, Elisabeth Baudin, et al.The Journal of Antimicrobial Chemotherapy|August 29, 2025
Pharmacokinetics of rifampicin and isoniazid in patients with HIV-tuberculosis coinfection receiving efavirenz-based antiretroviral treatment: an ANRS12292-RIFAVIRENZ sub-studyThibaut Gelé, Daniel Atwine, Elisabeth Baudin, et al.BMC Pregnancy and Childbirth|March 4, 2023
High severity of abortion complications in fragile and conflict-affected settings: a cross-sectional study in two referral hospitals in sub-Saharan Africa (AMoCo study)Estelle Pasquier, Onikepe O Owolabi, Tamara Fetters, et al.The Journal of Antimicrobial Chemotherapy|January 31, 2020
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trialDaniel Atwine, Elisabeth Baudin, Thibaut Gelé, et al.Lancet (London, England)|June 30, 2009
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialGerardo Priotto, Serena Kasparian, Wilfried Mutombo, et al.Pageof 2